An Echocardiographic Comparison of Sutureless and Conventional Aortic Valve Replacement: a Matched Case-Control Study
Abstract
Background Patients at a high operative risk for conventional aortic valve replacement (AVR) may be offered sutureless valve implantation. Sutureless valves resemble conventional valves but incorporate an anchoring mechanism without using annular sutures.
Methods Pre-operative and six month post-operative echocardiography data from our first year, single centre experience of sutureless valves was compared to conventional aortic valve replacements in patients matched for operative risk. Left ventricular ejection fraction, mean and peak AV gradients and inter-ventricular septal thickness, effective orifice area (EOA) and indexed effective orifice area (iEOA) were measured.
Results The drops in mean and peak pre- to post-operative gradients were greater in the sutureless group, p=0.039 and p=0.001 respectively. Post-operative EOA was 1.69 cm2 and 1.26 cm2 (p=0.001) in the sutureless and conventional groups. Similarly iEOA was 0.93 cm2 and 0.74 cm2 (p=0.001) in the sutureless and conventional groups. There was also a reduction in patient prosthesis mismatch (PPM) in the sutureless group as compared to the conventional group (Chi square test p=0.026). Post-operative inter-ventricular septal thickness was 1.13 cm2 in the sutureless group and 1.35 cm2 in the conventional group (p=0.011).
Conclusions Use of sutureless valves with a stent framework resulted in larger EOA and iEOA and a diminution in PPM; and lead to a statistically significant faster regression in inter-ventricular septal thickness that is a measure of left ventricular mass. The rate and extent of regression in left ventricular hypertrophy after AVR is important since it determines long-term survival including mortality, heart failure and decreased admission rates.
Keywords
Full Text:
PDFReferences
Lindroos M, Kupari M, Heikkilä J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21(5):1220-5.
Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29(3):630-4.
Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez- Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005–1011. DOI: 10.1016/S0140-6736(06)69208-8
Vahanian A, Otto CM. Risk stratification of patients with aortic stenosis. Eur Heart J. 2010;31:416–23. DOI: 10.1161/CIRCIMAGING.115.003421
Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975; 56: 56-64.
Russell B, Curtis MW, Koshman YE, Samarel AM. Mechanical Stress-Induced Sarcomere Assembly for Cardiac Muscle Growth in Length and Width. Journal of molecular and cellular cardiology. 2010;48(5):817-823. DOI: 10.1016/j.yjmcc.2010.02.016
Kupari M, Turto H, Lommi J: Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure? Eur Heart J. 2005, 26: 1790-1796. DOI: 10.1093/eurheartj/ehi290
Manché A., Camilleri L., & Gauci D. (2016). Does aortic valve replacement restore normal life expectancy? A twenty-year relative survival study. International Cardiovascular Forum Journal, 6, 46-53. DOI: https://doi.org/10.17987/icfj.v6i0.138
Lindblom D, Lindblom U, Qvist J, Lundstrom H: Long-term relative survival rates after heart valve replacement. J Am Coll Cardiol. 1990, 15: 566-573.
Lindman BR, Stewart WJ, Pibarot P, Hahn RT, Otto CM, Xu K et al. Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations. JACC Cardiovascular interventions. 2014;7(6):662-673. DOI: 10.1016/j.jcin.2014.02.011
Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26(24):2714–2720. DOI: 10.1093/eurheartj/ehi471
De Paulis R, Sommariva L, Colagrande L, De Matteis GM, Fratini S, Tomai F, Bassano C, Penta de Peppo A, Chiariello L. Regression of left ventricular hypertrophy after aortic valve replacement for aortic stenosis with different valve substitutes. J Thorac Cardiovasc Surg. 1998;116(4):590-8.
Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA et al. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound. J Am Soc Echocardiogr. 2009;22(9):975–1014. DOI: 10.1016/j.echo.2009.07.013
Pibarot P, Dumesnil JG. Prosthesis-patient mismatch: definition, clinical impact, and prevention. Heart. 2006;92(8):1022–9. DOI: 10.1136/hrt.2005.067363
Gilmanov D, Miceli A, Bevilacqua S, Farneti P, Solinas M, Ferrarini M et al. Sutureless implantation of the Perceval S aortic valve prosthesis through right anterior minithoracotomy. Ann Thorac Surg. 2013;96(6):2101–8. DOI: 10.1016/j.athoracsur.2013.07.007
Santarpino G, Fischlein T. Use of sutureless prosthetic aortic valves in cardiac surgery. G Ital Cardiol (Rome) 2014;15(3):170–6. DOI: 10.1714/1463.16167
Igor B, Stefano M, Mariachiara C, Davide S, Ottavio A. Early predictors of permanent pacemaker implantation in sutureless aortic valve replacement with Perceval bioprosthesis: a conduction disorders analysis. J Heart Health Cir 2016;1:1.
Lorusso R, Gelsomino S, De Cicco G, Vizzardi E, Faggiano P, Carella R et al. The Italian study on the Mitroflow postoperative results (ISTHMUS): a 20-year, multicentre evaluation of Mitroflow pericardial bioprosthesis. Eur J Cardiothorac Surg 2011;39(1):18–26. DOI: 10.1016/j.ejcts.2010.03.069
Jamieson WR, Koerfer R, Yankah CA, Zittermann A, Hayden RI, Ling H et al. Mitroflow aortic pericardial bioprosthesis–clinical performance. Eur J Cardiothorac Surg 2009;36(5):818–824. DOI: 10.1016/j.ejcts.2009.05.020
Shrestha M, Maeding I, Höffler K, Koigeldiyev N, Marsch G, Siemeni T et al. Aortic valve replacement in geriatric patients with small aortic roots: are sutureless valves the future? Interact Cardiovasc Thorac Surg 2013;17(5):778–782. DOI: 10.1093/icvts/ivt291
Sepehripour AH, Harling L, Athanasiou T. What are the current results of sutureless valves in high-risk aortic valve disease patients? Interact Cardiovasc Thorac Surg 2012;14(5):615–621. DOI: 10.1093/icvts/ivs011
Kulik A, Al-Saigh M, Chan V, Masters RG, Bédard P, Lam BK et al. Enlargement of the small aortic root during aortic valve replacement: is there a benefit? Ann Thorac Surg 2008;85(1):94–100. DOI: 10.1016/j.athoracsur.2007.07.058
Powell R, Pelletier MP, Chu MW, Bouchard D, Melvin KN, Adams C. The Perceval sutureless aortic valve: review of outcomes, complications, and future direction. Innovations (Phila) 2017;12(3):155-73. DOI: 110.1097/IMI.0000000000000372
Vogt F, Pfeiffer S, Dell’Aquila AM, Fischlein T, Santarpino G. Sutureless aortic valve replacement with Perceval bioprosthesis: are there predicting factors for postoperative pacemaker implantation? Interact Cardiovasc Thorac Surg 2016;22(3):253–8. DOI: 10.1093/icvts/ivv330
Kim JH, Kim JB, Choi SY. Sutureless aortic valve replacement in stentless bioprosthesis failure. Interact Cardiovasc Thorac Surg 2015; 21(6):801–802. DOI: 10.1093/icvts/ivv255
Santarpino G, Pfeiffer S, Concistrè G, Grossmann I, Hinzmann M, Fischlein T. The Perceval S aortic valve has the potential of shortening surgical time: does it also result in improved outcome? Ann Thorac Surg 2013;96(1):77–81. DOI: 10.1016/j.athoracsur.2013.03.083
Phan K, Tsai YC, Niranjan N, Bouchard D, Carrel TP, Dapunt OE et al. Sutureless aortic valve replacement: a systematic review and meta-analysis. Ann Cardiothorac Surg 2015;4(2):100–11. DOI: 10.3978/j.issn.2225-319X.2014.06.01
Santarpino G, Pfeiffer S, Jessl J, Dell'Aquila AM, Pollari F, Pauschinger M et al. Sutureless replacement versus transcatheter valve implantation in aortic valve stenosis: a propensity-matched analysis of 2 strategies in high-risk patients. J Thorac Cardiovasc Surg 2014;147(2):561–7. DOI: 10.1016/j.jtcvs.2013.10.025
Khoffi F, Heim F, Chakfe N, Lee JT. Transcatheter fiber heart valve: Effect of crimping on material performances. J Biomed Mater Res B Appl Biomater 2015;103(7):1488–97. DOI: 10.1002/jbm.b.33330
Laborde F, Fischlein T, Hakim-Meibodi K, Misfeld M, Carrel T, Zembala M, et al. Clinical and haemodynamic outcomes in 658 patients receiving the Perceval sutureless aortic valve: early results from a prospective European multicentre study (the Cavalier trial). Eur J Cardiothorac Surg 2016;49(3):978-86. DOI: 10.1093/ejcts/ezv257
Flameng W, Herregods MC, Hermans H, Van der Mieren G, Vercalsteren M, Poortmans G et al. Effect of sutureless implantation of the Perceval S aortic valve bioprosthesis on intraoperative and early postoperative outcomes. J Thorac Cardiovasc Surg 2011;142(6):1453-7. DOI: 10.1016/j.jtcvs.2011.02.021
Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol. 1998, 32: 1454-1459.
Villa E, Troise G, Cirillo M, Brunelli F, Tomba MD, Mhagna Z et al. Factors affecting left ventricular remodeling after valve replacement for aortic stenosis. An overview. Cardiovasc Ultrasound 2006;4:25. DOI: 10.1186/1476-7120-4-25
Tasca G, Brunelli F, Cirillo M, Dalla Tomba M, Mhagna Z, Troise G et al. Impact of valve prosthesis-patient mismatch on left ventricular mass regression following aortic valve replacement. Ann Thorac Surg 2005;79(2):505-510. DOI: 10.1016/j.athoracsur.2004.04.042
Ali A, Patel A, Ali Z, Abu-Omar Y, Saeed A, Athanasiou T et al. Enhanced left ventricular mass regression after aortic valve replacement in patients with aortic stenosis is associated with improved long-term survival. J Thorac Cardiovasc Surg 2011;142(2):285-91. DOI: 10.1016/j.jtcvs.2010.08.084
Une D, Mesana L, Chan V, Maklin M, Chan R, Masters RG et al. Clinical impact of changes in left ventricular function after aortic valve replacement: analysis from 3112 patients. Circulation 2015;132(8):741-7. DOI: 10.1161/CIRCULATIONAHA.115.015371
Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4
DOI: https://doi.org/10.17987/icfj.v14i0.536
Copyright (c) 2019 Aaron R Casha, Alexander Manché, Liberato Camilleri, Kentaro Yamagata, Stephanie Santucci, Marilyn Gauci, Joseph Galea

This work is licensed under a Creative Commons Attribution 4.0 International License.